Light-Sensing Biomarker Analyzer: A Solution for Therapeutic Drug Monitoring
In response to the needs of clinical medicine and detection, development for timely diagnosis and rapid screening has become a must-win battle in the area of biomedicine, and the Light-Sensing Biomarker Analyzer (Model No. INB D-200) developed by Instant NanoBiosensors which adopts the world’s first Fiber Optic Particle Plasmon Resonance (FOPPR) technology can shorten the time consumed in detecting biomarker, such as TNF-α、PCT、cTnI, at the laboratory from three hours and above typically to just several minutes, thus can complete on-site detection to assist the medical personnel in speeding up their diagnosis and make timely medical decisions to avoid missing out on the best timing for treating the patients and damage and waste of medical resources. In the future, prognostic tracing for the patients can be done more effectively through such portable device while transmitting data simultaneously to the back-end diagnosis cloud platform, therefore may realize the vision of “immediate care” to assist the patients in receiving further diagnosis and achieving the goal of self-health management.
待補
Orthopedic implants and surgical instruments in healing bone fracture.